中国学者近期发表的论文
1.	Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort. Author: Wang Q1,2, Gregg JR3, Gu J1, Ye Y1, Chang DW1, Davis JW3, Thompson TC4, Kim J3, Logothetis CJ4, Wu X1. Journal: Oncoimmunology. 2018 Oct 29;8(1):e1483303. doi: 10.1080/2162402X.2018.1483303. eCollection 2019.    PubMed      DOI
2.	DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cells. Author: Zhao R1,2,3, Cheng L1,2, Jiang Z1,2, Wei X1,2, Li B1,2, Wu Q1,2, Wang S1,2, Lin S1,2, Long Y1,2, Zhang X4, Wu Y4, Du X5, Pei D1,2, Liu P6, Li Y7, Cui S8, Yao Y1,2, Li P1,2,8. Journal: Oncoimmunology. 2018 Nov 2;8(1):e1509173. doi: 10.1080/2162402X.2018.1509173. eCollection 2019.    PubMed      DOI
3.	Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinoma. Author: Wang J1, Liu L1, Bai Q1, Ou C2, Xiong Y1, Qu Y1, Wang Z2, Xia Y1, Guo J1, Xu J2. Journal: Oncoimmunology. 2018 Oct 2;8(1):e1515611. doi: 10.1080/2162402X.2018.1515611. eCollection 2019.    PubMed      DOI
4.	lncRNA MALAT1 binds chromatin remodeling subunit BRG1 to epigenetically promote inflammation-related hepatocellular carcinoma progression. Author: Huang M1, Wang H1,2, Hu X1,3, Cao X1,2,3,4. Journal: Oncoimmunology. 2018 Oct 16;8(1):e1518628. doi: 10.1080/2162402X.2018.1518628. eCollection 2019.    PubMed      DOI
5.	Virotherapy-recruited PMN-MDSC infiltration of mesothelioma blocks antitumor CTL by IL-10-mediated dendritic cell suppression. Author: Tan Z1, Liu L1, Chiu MS1, Cheung KW1, Yan CW1, Yu Z1, Lee BK1, Liu W1, Man K2, Chen Z1,3. Journal: Oncoimmunology. 2018 Oct 16;8(1):e1518672. doi: 10.1080/2162402X.2018.1518672. eCollection 2019.    PubMed      DOI
6.	Mannan-binding lectin suppresses growth of hepatocellular carcinoma by regulating hepatic stellate cell activation via the ERK/COX-2/PGE2 pathway. Author: Li J1, Li H1, Yu Y1, Liu Y1, Liu Y1, Ma Q2, Zhang L1, Lu X1, Wang XY3, Chen Z1,4, Zuo D1,4,5,6, Zhou J1. Journal: Oncoimmunology. 2018 Oct 10;8(2):e1527650. doi: 10.1080/2162402X.2018.1527650. eCollection 2019.    PubMed      DOI
7.	Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy. Author: Zhou Y1,2, Chen CL1,3, Jiang SW1,2, Feng Y1,2, Yuan L4, Chen P1,5, Zhang L6, Huang S1,2, Li J1,2, Xia JC1,7, Zheng M1,2. Journal: Oncoimmunology. 2018 Nov 11;8(2):e1528411. doi: 10.1080/2162402X.2018.1528411. eCollection 2019.    PubMed      DOI
8.	ISG20 promotes local tumor immunity and contributes to poor survival in human glioma. Author: Gao M1, Lin Y1, Liu X2,3, Li Y2,3, Zhang C2,3, Wang Z2,3, Wang Z2,3, Wang Y1, Guo Z1. Journal: Oncoimmunology. 2018 Oct 31;8(2):e1534038. doi: 10.1080/2162402X.2018.1534038. eCollection 2019.    PubMed      DOI
9.	Genomic and transcriptional Profiling of tumor infiltrated CD8+ T cells revealed functional heterogeneity of antitumor immunity in hepatocellular carcinoma. Author: Li Z1,2, Chen G1,2,3, Cai Z1,2,3, Dong X1,2, Qiu L1,2, Xu H1,2, Zeng Y1,4,2, Liu X1,2, Liu J1,4,2. Journal: Oncoimmunology. 2018 Nov 10;8(2):e1538436. doi: 10.1080/2162402X.2018.1538436. eCollection 2019.    PubMed      DOI
10.	CD28H expression identifies resident memory CD8 + T cells with less cytotoxicity in human peripheral tissues and cancers. Author: Tian Y1,2, Sun Y1,3, Gao F4, Koenig MR1, Sunderland A1, Fujiwara Y1, Torphy RJ1, Chen L5, Edil BH1, Schulick RD1, Zhu Y1. Journal: Oncoimmunology. 2018 Nov 5;8(2):e1538440. doi: 10.1080/2162402X.2018.1538440. eCollection 2019.    PubMed      DOI

同类著名期刊名称 h-index CiteScore Cancer Immunology Research 62 8.58 Journal of Allergy and Clinical Immunology-In Practice 40 3.14 OncoImmunology 58 4.51 ALLERGOLOGY INTERNATIONAL 45 2.66 Allergy Asthma & Immunology Research 35 3.30 Immunity & Ageing 38 3.86 Infectious Agents and Cancer 30 2.38 Human Vaccines & Immunotherapeutics 43 2.21 Allergy Asthma and Clinical Immunology 26 2.64 Endocrine Metabolic & Immune Disorders-Drug Targets 44 1.96

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 299667 CANCER RESEARCH 165744 Molecular Medicine Reports 164528 International Journal of Nanomedicine 164291 CANCER LETTERS 159333 JOURNAL OF ETHNOPHARMACOLOGY 141517 BIOMEDICINE & PHARMACOTHERAPY 140375 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 135824 Theranostics 135771 International Journal of Environmental Research and Public Health 133459